Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000721748-13-000643
Filing Date
2013-10-03
Accepted
2013-10-03 14:35:46
Documents
10
Period of Report
2013-08-31

Document Format Files

Seq Description Document Type Size
1 gbiq10q0831fin.htm 10-Q 127739
2 CERTIFICATIONS gbiq10q0831ex311.htm EX-31.1 7192
3 CERTIFICATIONS gbiq10q0831ex312.htm EX-31.2 7475
4 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTIONS 1350 AS ADOPTED PURSUANT TO SECTIO gbiq10q0831ex321.htm EX-32.1 2770
  Complete submission text file 0000721748-13-000643.txt   1166338

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gbiq-20130831.xml EX-101.INS 79853
6 XBRL SCHEMA FILE gbiq-20130831.xsd EX-101.SCH 16354
7 XBRL CALCULATION FILE gbiq-20130831_cal.xml EX-101.CAL 14692
8 XBRL DEFINITION FILE gbiq-20130831_def.xml EX-101.DEF 18682
9 XBRL LABEL FILE gbiq-20130831_lab.xml EX-101.LAB 96699
10 XBRL PRESENTATION FILE gbiq-20130831_pre.xml EX-101.PRE 80829
Mailing Address 2711 CENTERVILLE SUITE 400 WILMINGTON DE 19808
Business Address 2550 BATES RD. SUITE 212 MONTREAL A8 H3S 1A7 302 288 0658
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

EIN.: 980229951 | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-33271 | Film No.: 131133234
SIC: 7389 Services-Business Services, NEC